164 related articles for article (PubMed ID: 30626816)
21. The renin-angiotensin-aldosterone system blockade in patients with advanced diabetic kidney disease.
Bermejo S; García CO; Rodríguez E; Barrios C; Otero S; Mojal S; Pascual J; Soler MJ
Nefrologia (Engl Ed); 2018; 38(2):197-206. PubMed ID: 29102270
[TBL] [Abstract][Full Text] [Related]
22. Stopping renin-angiotensin system inhibitors in chronic kidney disease: predictors of response.
Gonçalves AR; Khwaja A; Ahmed AK; El Kossi M; El Nahas M
Nephron Clin Pract; 2011; 119(4):c348-54. PubMed ID: 22135795
[TBL] [Abstract][Full Text] [Related]
23. Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population.
Afghahi H; Miftaraj M; Svensson AM; Hadimeri H; Gudbjörnsdottir S; Eliasson B; Svensson MK;
J Diabetes Complications; 2013; 27(3):229-34. PubMed ID: 23246248
[TBL] [Abstract][Full Text] [Related]
24. Effects of cilostazol and renin-angiotensin system (RAS) blockers on the renal disease progression of Korean patients: a retrospective cohort study.
Noh Y; Lee J; Shin S; Park I; Bae SK; Oh E; Lee S
Int J Clin Pharm; 2018 Feb; 40(1):160-168. PubMed ID: 29282632
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease.
Frimodt-Møller M; Høj Nielsen A; Strandgaard S; Kamper AL
Nephrol Dial Transplant; 2010 Mar; 25(3):842-7. PubMed ID: 19903661
[TBL] [Abstract][Full Text] [Related]
26. Renal safety and survival among acutely ill hospitalized patients treated by blockers of the Renin-Angiotensin axis or loop diuretics: a single-center retrospective analysis.
Assaly M; Gorelik Y; Heyman SN; Abassi Z; Khamaisi M
Ren Fail; 2023; 45(2):2282707. PubMed ID: 37975172
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis.
Susantitaphong P; Sewaralthahab K; Balk EM; Eiam-ong S; Madias NE; Jaber BL
Am J Hypertens; 2013 Mar; 26(3):424-41. PubMed ID: 23382494
[TBL] [Abstract][Full Text] [Related]
28. Management of renin-angiotensin system blockade in patients with chronic kidney disease under specialist care. Retrospective cross-sectional study.
Tylicki L; Jakubowska A; Lizakowski S; Świetlik D; Rutkowski B
J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):145-52. PubMed ID: 25324423
[TBL] [Abstract][Full Text] [Related]
29. Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors.
Terano C; Ishikura K; Miura M; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Ando T; Honda M
Eur J Pediatr; 2016 May; 175(5):631-7. PubMed ID: 26687571
[TBL] [Abstract][Full Text] [Related]
30. Effects of direct renin inhibition versus angiotensin II receptor blockade on angiotensin profiles in non-diabetic chronic kidney disease.
Antlanger M; Bernhofer S; Kovarik JJ; Kopecky C; Kaltenecker CC; Domenig O; Poglitsch M; Säemann MD
Ann Med; 2017 Sep; 49(6):525-533. PubMed ID: 28358246
[TBL] [Abstract][Full Text] [Related]
31. Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors.
Dattolo PC; Gallo P; Michelassi S; Paudice N; Cannavò R; Romoli E; Fani F; Tsalouchos A; Mehmetaj A; Ferro G; Sisca S; Pizzarelli F
J Nephrol; 2016 Dec; 29(6):809-815. PubMed ID: 27015900
[TBL] [Abstract][Full Text] [Related]
32. Dual renin-angiotensin system blockade for nephroprotection.
Ruggenenti P
Nephrol Ther; 2017 Apr; 13 Suppl 1():S43-S45. PubMed ID: 28577742
[TBL] [Abstract][Full Text] [Related]
33. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
[TBL] [Abstract][Full Text] [Related]
34. Analysis from the EMPA-REG OUTCOME
Mayer GJ; Wanner C; Weir MR; Inzucchi SE; Koitka-Weber A; Hantel S; von Eynatten M; Zinman B; Cherney DZI
Kidney Int; 2019 Aug; 96(2):489-504. PubMed ID: 31142441
[TBL] [Abstract][Full Text] [Related]
35. Acute kidney injury secondary to a combination of renin-angiotensin system inhibitors, diuretics and NSAIDS: "The Triple Whammy".
Camin RM; Cols M; Chevarria JL; Osuna RG; Carreras M; Lisbona JM; Coderch J
Nefrologia; 2015; 35(2):197-206. PubMed ID: 26300514
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin blockade and progressive loss of kidney function in hemodialysis patients: a randomized controlled trial.
Kjaergaard KD; Peters CD; Jespersen B; Tietze IN; Madsen JK; Pedersen BB; Novosel MK; Laursen KS; Bibby BM; Strandhave C; Jensen JD
Am J Kidney Dis; 2014 Dec; 64(6):892-901. PubMed ID: 25011693
[TBL] [Abstract][Full Text] [Related]
37. Reduction in urinary angiotensinogen levels and improvement of proteinuria by renin-angiotensin system blockade in pediatric chronic kidney disease patients with very low birth weight.
Yamamura-Miyazaki N; Michigami T; Satomura K; Urushihara M; Kagami S; Yamamoto K
Pediatr Nephrol; 2020 Jul; 35(7):1307-1314. PubMed ID: 32162100
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of renin-angiotensin system inhibitors for patients with heart failure with preserved ejection fraction and mild to moderate chronic kidney disease.
Tsujimoto T; Kajio H
Eur J Prev Cardiol; 2018 Aug; 25(12):1268-1277. PubMed ID: 29808753
[TBL] [Abstract][Full Text] [Related]
39. Blockade of Renin-Angiotensin-Aldosterone System in Elderly Patients with Heart Failure and Chronic Kidney Disease: Results of a Single-Center, Observational Cohort Study.
Martínez-Milla J; García MC; Urquía MT; Castillo ML; Arbiol AD; Monteagudo ALR; Mariscal MLM; Figuero SB; Franco-Pelaéz JA; Tuñón J
Drugs Aging; 2019 Dec; 36(12):1123-1131. PubMed ID: 31493202
[TBL] [Abstract][Full Text] [Related]
40. Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease.
Haynes R; Judge PK; Staplin N; Herrington WG; Storey BC; Bethel A; Bowman L; Brunskill N; Cockwell P; Hill M; Kalra PA; McMurray JJV; Taal M; Wheeler DC; Landray MJ; Baigent C
Circulation; 2018 Oct; 138(15):1505-1514. PubMed ID: 30002098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
